Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2
Neurology Minute
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype Show reference:
info_outline
AAN’s President’s Award Recipient for 2025 - Part 2
Neurology Minute
In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN. Show reference:
info_outline
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1
Neurology Minute
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project. Show reference:
info_outline
AAN’s President’s Award Recipient for 2025 - Part 1
Neurology Minute
In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference:
info_outline
Progressive Multiple Sclerosis
Neurology Minute
Dr. Jeff Lambe talks about progressive multiple sclerosis. Show references:
info_outline
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
Neurology Minute
Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes. Show reference:
info_outline
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2
Neurology Minute
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
info_outline
Spontaneous Intracranial Hypotension Updates
Neurology Minute
Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.
info_outline
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
Neurology Minute
In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.
info_outline
Neuroimmunology Update 2025: MOGAD Treatments
Neurology Minute
Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references:
info_outlineDr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.
Show reference: